The evolving high: New designer drugs of abuse

Human and Experimental Toxicology

Volumn 33, Issue 10, 2014, Pages 993-999

  Pourmand, A ^a   Armstrong, P ^a   Mazer Amirshahi, M ^a   Shokoohi, H ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Drug abuse; human toxicology; poisoning

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; CANNABINOID; CATHINONE; DESIGNER DRUG; DESOMORPHINE; KRATOM; METHOXETAMINE; OPIATE; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT; PHENCYCLIDINE;

ARTICLE; DRUG ABUSE; DRUG INTOXICATION; HUMAN; PRIORITY JOURNAL; SALVIA DIVINORUM; SCREENING TEST; SYMPTOMATOLOGY; UNITED STATES; ANALOGS AND DERIVATIVES; ANIMAL; INTOXICATION; OPIOID-RELATED DISORDERS; RISK FACTOR; SYNTHESIS;

AMPHETAMINE-RELATED DISORDERS; AMPHETAMINES; ANALGESICS, OPIOID; ANIMALS; DESIGNER DRUGS; HUMANS; OPIOID-RELATED DISORDERS; PHENCYCLIDINE; PHENCYCLIDINE ABUSE; POISONING; RISK FACTORS;

EID: 84904693314     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327113514100     Document Type: Article

References (34)

1. Synthetic Drugs. Office of national drug control policy, http://www.whitehouse.gov/sites/default/files/page/files/synthetic-drugs-fact-sheet-455-2-15-12.pdf (2012, accessed 2 September 2013).
2. Fact Sheet: The 2012 Arrestee Drug Abuse Monitoring Program II (ADAM). Office of National Drug Control Policy, http://www.whitehouse.gov/sites/default/files/ondcp/Fact-Sheets/adamfactsheet-for-web.pdf. (2013, accessed 8 June 2013).
3. Drug Abuse Warning Network, 2010: National estimates of drug-related emergency department visits. Substance abuse and mental health services administrationhttp://www.samhsa.gov/data/2k13/DAWN2k10ED/DAWN2k10ED.htm. (2012, accessed 8 June 2013).
4. Schneir AB, Cullen J, Ly BT. "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med. 2011 ; 40 (3). 296-299
5. Hu X, Primack BA, Barnett TE, et al. College students and the use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy. 2011 ; 6: 16
6. Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow... and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol. 2012 ; 8 (1). 15-32
7. Lapoint J, James LP, Moran CL, et al. Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila). 2011 ; 49 (8). 760-764
8. Bonkowsky JL, Sarco D, Pomeroy SL. Ataxia and shaking in a 2-year-old girl: acute marijuana intoxication presenting as seizure. Pediatr Emerg Care. 2005 ; 21 (8). 527-528
9. Harris CR, Brown A. Synthetic cannabinoid intoxication: a case series and review. J Emerg Med. 2013 ; 44 (2). 360-366
10. Wiegand TJ, Wax PM, Schwartz T, Finkelstein Y, Gorodetsky R, Brent J. The toxicology investigators consortium case registry: the 2011 experience. J Med Toxicol. 2012 ; 8 (4). 360-377
11. Slomski A. A trip on "bath salts" is cheaper than meth or cocaine but much more dangerous. JAMA. 2012 ; 308 (23). 2445-2447
12. Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol. 2012 ; 8 (1). 33-42
13. Olives TD, Orozco BS, Stellpflug SJ. Bath salts: the ivory wave of trouble. West J Emerg Med. 2012 ; 13 (1). 58-62
14. Synthetic Drugs (a.k.a. K2, Spice, Bath Salts, etc.). Office of National Drug Control Policy, http://www.whitehouse.gov/ondcp/ondcp-fact-sheets/synthetic-drugs-k2-spice-bath-salts (2012, accessed 8 Jun 2013).
15. Drug Facts: Synthetic Cathinones. National Institute on Drug Abuse, http://www.drugabuse.gov. (2012, accessed 8 June 2013).
16. Russo R, Marks N, Morris K, et al. Life-threatening necrotizing fasciitis due to "bath salts" injection. Orthopedics. 2012 ; 35 (1). e124 - e127
17. Warrick BJ, Hill M, Hekman K, et al. A 9-state analysis of designer stimulant, "bath salt," hospital visits reported to poison control centers. Ann Emerg Med. 2013 ; 62 (3). 244-251
18. Miotto K, Striebel J, Cho AK, et al. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports. Drug Alcohol Depend. 2013 ; 132 ((1-2)). 1-12
19. Gerona RR, Wu AH. Bath salts. Clin Lab Med. 2012 ; 32 (3). 415-427
20. Torrance H, Cooper G. The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Forensic Sci Int. 2010 ; 202 ((1-3)). e62 - e63
21. Flomenbaum N, Goldfrank L, Hoffman R Goldfrank's toxicologic emergencies. 8 th ed. New York, NY: McGraw-Hill, 2006. New York, NY: McGraw-Hill ; 2006 :
22. Hoffman BL Goodman and Gillman's the pharmacologic basis of therapeutics. 9 th ed. New York, NY: McGraw-Hill, 1996. New York, NY: McGraw-Hill ; 1996 :
23. Scheduling Actions: Chronologic Order. Office of Diversion Control: Drug Enforcement Administration,http://www.deadiversion.usdoj.gov/schedules (2012, accessed 10 June 2013).
24. Drug Fact Sheet: Ecstasy or MDMA. Drug Enforcement Administration,http://www.justice.gov/dea/pr/multimedia-library/publications/drug-of-abuse.pdf#page=60 (2011, accessed 10 June 2013).
25. Okunoye G, Dutton P. Acute myocardial infarction in pregnancy following unlicensed use of methylenedioxymethamphetamine ("ecstasy"). Scott Med J. 2013 ; 58 (3). e4 - e6
26. Hartung TK, Schofield E, Short AI, et al. Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") ingestion. QJM. 2002 ; 95 (7). 431-437
27. Henry JA, Fallon JK, Kicman AT, et al. Low-dose MDMA ("ecstasy") induces vasopressin secretion. Lancet. 1998 ; 351 (9118). 1784
28. Boyer EW, Babu KM, Adkins JE, et al. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008 ; 103 (6). 1048-1050
29. Kratom: Drug Fact Sheet. Drug Enforcement Administration, http://www.justice.gov/dea/pr/multimedia-library/publications/drug-of-abuse.pdf#page=60. (2011, accessed 8 June 2013).
30. Zawilska JB, Wojcieszak J. Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug. Hum Psychopharmacol. 28: 403-412
31. Nelsen JL, Lapoint J, Hodgman MJ, et al. Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure. J Med Toxicol. 2010 ; 6 (4). 424-426
32. Gahr M, Freudenmann RW, Hiemke C, et al. "Krokodil": revival of an old drug with new problems. Subst Use Misuse. 2012 ; 47 (7). 861-863
33. International Overdose Awareness Day2012: Update from Eastern Europe and Central Asia. Eurasian Harm Reduction Network, http://www.idhdp.com. (2012, accessed June 2013).
34. Hofer KE, Grager B, Müller DM, et al. Ketamine-like effects after recreational use of methoxetamine. Ann Emerg Med. 2012 ; 60 (1). 97-99